133 related articles for article (PubMed ID: 2112165)
21. Double-blind study comparing erythromycin and mupirocin for treatment of impetigo in children: implications of a high prevalence of erythromycin-resistant Staphylococcus aureus strains.
Dagan R; Bar-David Y
Antimicrob Agents Chemother; 1992 Feb; 36(2):287-90. PubMed ID: 1605593
[TBL] [Abstract][Full Text] [Related]
22. Mupirocin resistance among Iranian isolates of Staphylococcus aureus.
Saderi H; Owlia P; Habibi M
Med Sci Monit; 2008 Oct; 14(10):BR210-3. PubMed ID: 18830185
[TBL] [Abstract][Full Text] [Related]
23. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.
Casewell MW; Hill RL
J Antimicrob Chemother; 1985 May; 15(5):523-31. PubMed ID: 3924877
[TBL] [Abstract][Full Text] [Related]
24. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
25. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
Maple PA; Hamilton-Miller JM; Brumfitt W
Lancet; 1989 Mar; 1(8637):537-40. PubMed ID: 2564067
[TBL] [Abstract][Full Text] [Related]
26. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients.
Shahsavan S; Emaneini M; Noorazar Khoshgnab B; Khoramian B; Asadollahi P; Aligholi M; Jabalameli F; Eslampour MA; Taherikalani M
Burns; 2012 May; 38(3):378-82. PubMed ID: 22040930
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
[TBL] [Abstract][Full Text] [Related]
28. Eradication of low-level methicillin-resistant Staphylococcus aureus skin colonization with topical mupirocin.
Denning DW; Haiduven-Griffiths D
Infect Control Hosp Epidemiol; 1988 Jun; 9(6):261-3. PubMed ID: 3136203
[No Abstract] [Full Text] [Related]
29. Staphylococcus aureus resistant to mupirocin.
Smith GE; Kennedy CT
J Antimicrob Chemother; 1988 Jan; 21(1):141-2. PubMed ID: 3128519
[No Abstract] [Full Text] [Related]
30. Adaptation of methicillin-resistant Staphylococcus aureus during antibiotic therapy.
Menzies RE; Cornere BM; MacCulloch D
J Antimicrob Chemother; 1989 Jun; 23(6):923-7. PubMed ID: 2503489
[TBL] [Abstract][Full Text] [Related]
31. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
Orrett FA
Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis.
Tang CS; Wang CC; Huang CF; Chen SJ; Tseng MH; Lo WT
Pediatr Int; 2011 Jun; 53(3):363-7. PubMed ID: 20723106
[TBL] [Abstract][Full Text] [Related]
33. A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains.
Pastagia M; Euler C; Chahales P; Fuentes-Duculan J; Krueger JG; Fischetti VA
Antimicrob Agents Chemother; 2011 Feb; 55(2):738-44. PubMed ID: 21098252
[TBL] [Abstract][Full Text] [Related]
34. Development of Emulgel Delivery of Mupirocin for Treatment of Skin Infection.
Jagdale SC; Kothekar PV
Recent Pat Antiinfect Drug Discov; 2020; 15(2):137-156. PubMed ID: 32814540
[TBL] [Abstract][Full Text] [Related]
35. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
37. Characterization of community-associated Staphylococcus aureus from skin and soft-tissue infections: a multicenter study in China.
Liu Y; Xu Z; Yang Z; Sun J; Ma L
Emerg Microbes Infect; 2016 Dec; 5(12):e127. PubMed ID: 27999423
[TBL] [Abstract][Full Text] [Related]
38. Mupirocin-resistant Staphylococcus aureus.
Lancet; 1987 Aug; 2(8555):387-8. PubMed ID: 2886836
[No Abstract] [Full Text] [Related]
39. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
Bernard P; Jarlier V; Santerre-Henriksen A
Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
[TBL] [Abstract][Full Text] [Related]
40. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance.
Hill RL; Casewell MW
Drugs Exp Clin Res; 1990; 16(8):397-402. PubMed ID: 2129029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
